Novartis

Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for…

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III…

V tokratni epizodi podkasta Tehnološki velikani gostimo dva moža, ki sta v samem središču preobrazbe, ki Slovenijo postavlja…

Novartis in Slovenia raises awareness about the visible and invisible potentials of persons with disabilities on the International…

Novartis LLC and the University of Ljubljana have signed a strategic cooperation agreement to further strengthen their partnership…

Drei Botschaften von Buffett und die große Cannabis-Frage | WELT Podcast Das ist alles auf Aktien gleich geht’s…

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)